In the glucose-deficient TME, its key participants involved in anti-tumor immune regulation, CD4+TILs, CD8+TILs, MDSCs, M1/M2 TAMs, Tregs and other immune cells (Table 1), are dysfunctional due to metabolic reprogramming (69, 70) (Figure 1). This evidence concerns the gene CD4 and neoplasm.